The connection between glucose metabolism and PD is supported by clinical and preclinical studies, which demonstrate that alterations in insulin signaling, mitochondrial dysfunction, oxidative stress, and neuroinflammation significantly affect disease progression. Here, INS is linked to Parkinson disease.